“How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.”

— Robert G. Allen

MYMD

This Biotech company caught my eye

This Biotech company caught my eye

  Sponsored by:     If you’ve been following our updates, you know that MYMD-1® seeks to target the CAUSE, not just the symptoms, that drive autoimmunity and inflammation. However, did you also know that MYMD-1® may behave like an ANTIDEPRESSANT? This...

MyMD battling brain-related disorders – let’s gooooo

MyMD battling brain-related disorders – let’s gooooo

    Sponsored By Recently we’ve been following the story of MyMD, particularly in regard to its lead drug indication – MYMD-1® – in Phase 2 trials for sarcopenia (aka aging).  But what led MyMD to pursue this path? As all companies have limited resources,...

Injection, infusion or pill…hmmm🤔

Injection, infusion or pill…hmmm🤔

  Sponsored By Hello Traders-Jeff Bishop Here! If you’ve been following our updates about MyMD, you know we’ve been focusing primarily on MYMD-1® and its Phase 2 trial as a therapy for delaying aging and prolonging healthy lifespan.  To do this, MYMD-1® is...

Scientists Are Obsessed with THESE TWO Questions

Scientists Are Obsessed with THESE TWO Questions

  Sponsored By Greetings Traders, “What causes a person’s body to attack itself?” and “Why is a particular tissue selected as the target?” Although these questions have completely stumped scientists, what happens to the body has not.  Autoimmune diseases wreak...

MYMD raises cash as catalysts approach

MYMD raises cash as catalysts approach

          Sponsored By See Disclosure Below Hello again, Now that MYMD has improved their cash position through an offering and retraced to $3, let’s take a look why I like it here based on the chart and upcoming catalysts.    ...

This stock needs to be on your radar, again

This stock needs to be on your radar, again

  Sponsored By See Disclosure Below Take note, Trader! It has been over a week since I talked about MYMD. As you know, I have been bullish on MyMD for some time now. Why should you care about this tiny biotech stock? For starters, I think that anyone 40 years...

MYMD on FOX

MYMD on FOX

  Sponsored by MYMD See Disclosure Below Hello, I hope you have been paying attention to what has been happening with MYMD lately?   It is the very first company that we have chosen to work with directly and share with our audience.   As you can imagine, I get a...

MyMD Squeeze Play? Check it out!

MyMD Squeeze Play? Check it out!

  Sponsored by:     Is a squeeze coming on MYMD soon? Let’s dig in. ⛏ In 360 Wall Street, we do a lot of momentum trading.  One of the big things we look for is positively stacked EMAs. (Exponential Moving Averages) Momentum tends to play out over a few...

MYMD; the anatomy of trading breakouts

MYMD; the anatomy of trading breakouts

Sponsored By:      Good morning trader! ☕ After MYMD had a monster move from under $2 to nearly $5 recently, it touched (almost perfectly) a 38.2% Fibonacci retracement and acted as a springboard for the stock yesterday, which finished up over 10% on the...

Boardroom 7/17- MYMD Fibonacci setup

Boardroom 7/17- MYMD Fibonacci setup

👋Good morning, It’s very common for stocks to make significant moves higher. And one of the biggest mistakes traders make is getting caught up in the FOMO (fear of missing out) and chasing the move near the top when waiting for a retracement would be a wiser play. So...